<html>
<head>PUBMED IDs for ELOB</head>
<body bgcolor='#C5F0F2'><h1>ELOB</h1><a href='https://pubmed.ncbi.nlm.nih.gov/22190037/'>Vif hijacks CBF-β to degrade APOBEC3G and promote HIV-1 infection.</a> March 7  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/24402281/'>Structural basis for hijacking CBF-β and CUL5 E3 ligase complex by HIV-1 Vif.</a> January 31  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24402277/'>HIV: Ringside views.</a> January 31  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/26411101/'>IMMUNOEXPRESSION OF TWIST IN DIFFERENT MORPHOLOGICAL VARIANTS OF AMELOBLASTOMAS.</a> October 27  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26762204/'>Identification of Patients with Recurrent Glioblastoma Who May Benefit from Combined Bevacizumab and CCNU Therapy: A Report from the BELOB Trial.</a> June 29  2016<br></body></html>
